Compare Stocks: IDXX, NVST, ISRG, and MDT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IDXX IDEXX Laboratories	$510.73 +0.2%	$553.29	$500.61 ▼ $769.98	$40.14B	1.54	459,213 shs	603,637 shs
ISRG Intuitive Surgical	$377.16 -0.2%	$374.17	$328.57 ▼ $603.88	$133.52B	1.47	2.17 million shs	1.98 million shs
MDT Medtronic	$93.73 -0.1%	$88.33	$73.31 ▼ $106.33	$119.98B	0.56	7.61 million shs	7.15 million shs
NVST Envista	$24.76 -4.0%	$27.06	$18.77 ▼ $30.42	$4.14B	0.86	2.05 million shs	4.75 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IDXX IDEXX Laboratories	+0.96%	-4.82%	-7.51%	-11.07%	-20.52%
ISRG Intuitive Surgical	+2.38%	+3.07%	-4.20%	-9.38%	-15.95%
MDT Medtronic	+3.19%	-0.26%	+3.04%	+15.38%	-0.19%
NVST Envista	+1.09%	-4.91%	-8.05%	+4.16%	+22.53%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IDXX IDEXX Laboratories	$510.73 +0.2%	$553.29	$500.61 ▼ $769.98	$40.14B	1.54	459,213 shs	603,637 shs
ISRG Intuitive Surgical	$377.16 -0.2%	$374.17	$328.57 ▼ $603.88	$133.52B	1.47	2.17 million shs	1.98 million shs
MDT Medtronic	$93.73 -0.1%	$88.33	$73.31 ▼ $106.33	$119.98B	0.56	7.61 million shs	7.15 million shs
NVST Envista	$24.76 -4.0%	$27.06	$18.77 ▼ $30.42	$4.14B	0.86	2.05 million shs	4.75 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IDXX IDEXX Laboratories	+0.96%	-4.82%	-7.51%	-11.07%	-20.52%
ISRG Intuitive Surgical	+2.38%	+3.07%	-4.20%	-9.38%	-15.95%
MDT Medtronic	+3.19%	-0.26%	+3.04%	+15.38%	-0.19%
NVST Envista	+1.09%	-4.91%	-8.05%	+4.16%	+22.53%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IDXX IDEXX Laboratories	2.60	Moderate Buy	$747.00	46.26% Upside
ISRG Intuitive Surgical	2.68	Moderate Buy	$508.68	34.87% Upside
MDT Medtronic	2.68	Moderate Buy	$103.92	10.87% Upside
NVST Envista	2.56	Moderate Buy	$29.71	20.03% Upside

Current Analyst Ratings Breakdown

Latest IDXX, NVST, ISRG, and MDT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/10/2026	NVST Envista	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform
9/8/2026	ISRG Intuitive Surgical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$469.00
9/4/2026	MDT Medtronic	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
9/3/2026	MDT Medtronic	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$92.00
9/3/2026	MDT Medtronic	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$100.00 ➝ $110.00
9/3/2026	NVST Envista	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$32.00
9/3/2026	NVST Envista	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$29.00 ➝ $32.00
9/2/2026	MDT Medtronic	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$115.00
9/2/2026	MDT Medtronic	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$95.00 ➝ $110.00
9/2/2026	MDT Medtronic	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$102.00 ➝ $104.00
9/2/2026	MDT Medtronic	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$86.00 ➝ $99.00

(Data available from 9/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IDXX IDEXX Laboratories	$4.30B	9.35	$15.12 per share	33.78	$20.10 per share	25.41
ISRG Intuitive Surgical	$10.06B	13.24	$9.26 per share	40.74	$50.52 per share	7.47
MDT Medtronic	$36.36B	3.30	$7.84 per share	11.95	$39.75 per share	2.36
NVST Envista	$2.72B	1.46	$2.08 per share	11.88	$18.89 per share	1.31

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IDXX IDEXX Laboratories	$1.06B	$14.22	35.92	30.73	2.72	25.03%	71.96%	33.60%	11/2/2026 (Estimated)
ISRG Intuitive Surgical	$2.86B	$8.73	43.20	37.64	2.85	28.45%	16.91%	14.83%	10/20/2026 (Estimated)
MDT Medtronic	$4.80B	$4.06	23.09	14.67	2.20	13.93%	14.78%	7.97%	11/17/2026 (Estimated)
NVST Envista	$47M	$0.58	42.68	15.00	1.23	3.33%	7.88%	4.33%	11/4/2026 (Estimated)

Latest IDXX, NVST, ISRG, and MDT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/1/2026	Q1 2027	MDT Medtronic	$1.39	$1.45	+$0.06	$1.14	$9.55 billion	$9.76 billion
8/5/2026	Q2 2026	NVST Envista	$0.3353	$0.41	+$0.0747	$0.33	$716.11 million	$730.50 million
8/4/2026	Q2 2026	IDXX IDEXX Laboratories	$3.94	$4.27	+$0.33	$4.27	$1.20 billion	$1.22 billion
7/16/2026	Q2 2026	ISRG Intuitive Surgical	$2.48	$2.80	+$0.32	$2.29	$2.83 billion	$2.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
IDXX IDEXX Laboratories	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
MDT Medtronic	$2.88	3.07%	+4.13%	70.94%	49 Years
NVST Envista	N/A	N/A	N/A	N/A	N/A

Latest IDXX, NVST, ISRG, and MDT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/20/2026	MDT Medtronic	quarterly	$0.72	3.12%	9/25/2026	9/25/2026	10/16/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IDXX IDEXX Laboratories	0.19	1.17	0.87
ISRG Intuitive Surgical	N/A	4.96	3.91
MDT Medtronic	0.50	2.07	1.54
NVST Envista	0.47	2.43	2.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IDXX IDEXX Laboratories	87.84%
ISRG Intuitive Surgical	83.64%
MDT Medtronic	82.06%
NVST Envista	N/A

Insider Ownership

Company	Insider Ownership
IDXX IDEXX Laboratories	0.79%
ISRG Intuitive Surgical	0.60%
MDT Medtronic	0.27%
NVST Envista	0.99%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IDXX IDEXX Laboratories	11,000	78.78 million	78.16 million	Optionable
ISRG Intuitive Surgical	17,021	353.28 million	351.16 million	Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable
NVST Envista	12,000	160.62 million	159.03 million	Optionable

IDXX, NVST, ISRG, and MDT Headlines

Recent News About These Companies

Envista Holdings Corporation (NVST) Presents at 2026 Global Healthcare Conference Transcript

September 15 at 3:00 PM | seekingalpha.com

Corient Private Wealth LP Purchases 185,687 Shares of Envista Holdings Corporation $NVST

September 15 at 3:43 AM | marketbeat.com

WINTON GROUP Ltd Has $5.06 Million Holdings in Envista Holdings Corporation $NVST

September 11, 2026 | marketbeat.com

NVST or ABT: Which Is the Better Value Stock Right Now?

September 9, 2026 | zacks.com

Public Employees Retirement System of Ohio Purchases New Position in Envista Holdings Corporation $NVST

September 9, 2026 | marketbeat.com

Envista Announces Participation in Baird 2026 Global Healthcare Conference

September 8, 2026 | prnewswire.com

JP Morgan Upgrades Envista Holdings (NVST) to Overweight from Neutral

September 5, 2026 | msn.com

Envista (NYSE:NVST) Raised to "Overweight" at JPMorgan Chase & Co.

September 5, 2026 | americanbankingnews.com

Envista (NYSE:NVST) Cut to "Buy" at Wall Street Zen

September 5, 2026 | americanbankingnews.com

Envista (NYSE:NVST) Downgraded to Buy Rating by Wall Street Zen

September 5, 2026 | marketbeat.com

Envista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?

September 4, 2026 | zacks.com

Wellington Management Group LLP Purchases 1,625,360 Shares of Envista Holdings Corporation $NVST

September 4, 2026 | marketbeat.com

Legal & General Group Plc Acquires New Stake in Envista Holdings Corporation $NVST

September 4, 2026 | marketbeat.com

Envista Holdings Corporation : JPMorgan Chase passe de neutre à achat

September 3, 2026 | zonebourse.comZ

Envista Holdings shares rise after JPMorgan upgrade

September 3, 2026 | msn.com

Envista upgraded at J.P. Morgan on Investor Day expectations

September 3, 2026 | seekingalpha.com

Envista (NYSE:NVST) Stock Rating Upgraded by JPMorgan Chase & Co.

September 3, 2026 | marketbeat.com

The Manufacturers Life Insurance Company Buys Shares of 107,320 Envista Holdings Corporation $NVST

September 2, 2026 | marketbeat.com

Cookson Peirce & Co. Inc. Has $348,000 Stock Position in Envista Holdings Corporation $NVST

August 31, 2026 | marketbeat.com

Canada Pension Plan Investment Board Takes Position in Envista Holdings Corporation $NVST

August 31, 2026 | marketbeat.com

Jupiter Topco LLC Acquires New Holdings in Envista Holdings Corporation $NVST

August 30, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IDXX, NVST, ISRG, and MDT Company Descriptions

IDEXX Laboratories NASDAQ:IDXX

$510.73 +1.17 (+0.23%)

Closing price 04:00 PM Eastern

Extended Trading

$511.24 +0.51 (+0.10%)

As of 07:55 PM Eastern

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Intuitive Surgical NASDAQ:ISRG

$377.16 -0.78 (-0.21%)

Closing price 04:00 PM Eastern

Extended Trading

$377.40 +0.24 (+0.06%)

As of 07:59 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Medtronic NYSE:MDT

$93.73 -0.07 (-0.07%)

Closing price 03:59 PM Eastern

Extended Trading

$93.80 +0.07 (+0.07%)

As of 08:00 PM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Envista NYSE:NVST

$24.76 -1.04 (-4.01%)

Closing price 03:59 PM Eastern

Extended Trading

$24.74 -0.02 (-0.08%)

As of 08:00 PM Eastern

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IDXX, NVST, ISRG, and MDT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IDXX, NVST, ISRG, and MDT Earnings

Compare Dividends

Latest IDXX, NVST, ISRG, and MDT Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IDXX, NVST, ISRG, and MDT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

IDXX, NVST, ISRG, and MDT Company Descriptions

IDEXX Laboratories NASDAQ:IDXX

Intuitive Surgical NASDAQ:ISRG

Medtronic NYSE:MDT

Envista NYSE:NVST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools